CrystEngComm
Paper
Ts-(Aib)5-OMe 1 (ref. 4)
data were integrated, and the absorption correction was
calculated using the Rigaku CrystalClear, CrysAlisPro program
package. The structures were solved by SHELXT version 2014/5
and refined by full-matrix least-squares fitting on F2 (SHELXL
versions 2014/7 and 2018/3).7 All non-hydrogen atoms were
refined anisotropically. All N–H hydrogen atoms of the
sulfonamides were found by difference Fourier synthesis. The
other hydrogen atoms were located on the calculated positions.
The crystal data and the structure refinements are summarized
in Tables 1 and S1.† Crystallographic data have been deposited
with the Cambridge Crystallographic Data Center as
supplementary publication numbers CCDC 2022589–2022593.
mp 230–235 °C; IR (KBr) (cm−1): 3337, 1738, 1667, 1651,
1
1526; H NMR (400 MHz, CDCl3): δ 1.36 (s, 6H), 1.48 (s, 6H),
1.51 (s, 6H), 1.53 (s, 6H), 2.46 (s, 3H), 3.69 (s, 3H), 5.47 (br s,
1H), 7.01 (br s, 1H), 7.25 (br s, 1H), 7.33–7.39 (m, 3H), 7.46
(br s, 1H), 7.74 (d, J = 6.4 Hz, 2H); 13C-NMR (100 MHz,
DMSO-d6): δ 21.5, 24.8, 25.2, 25.3, 25.5, 25.8, 52.1, 55.3, 56.2,
56.5, 56.7, 59.2, 79.7, 126.7, 130.1, 140.8, 143.3, 173.6, 174.4,
175.0, 175.3; MS (FAB): m/z 612 [M + H]+; HRMS-FAB: m/z [M
+ Na]+ calcd for C28H45N5O8SNa 634.2887, found 634.2888.
ArSO2-(Aib)5-OMe (Ar = p-bromophenyl) 2
Following the typical procedure for the preparation of
sulfonamides, the reaction of H-(Aib)5-OMe 13 (68.8 mg, 0.15
mmol) with p-bromobenzenesulfonyl chloride (39.4 mg, 0.154
mmol) afforded crude product 2 (53.6 mg, 0.0794 mmol,
53%), which was recrystallized in n-hexane (2 mL)/CHCl3 (1
mL) to give the pure product 2 (25.3 mg, 0.0375 mmol, 25%)
as a white solid. mp 271–277 °C; IR (KBr) (cm−1): 3424, 3357,
Results and discussion
Conformations of pentapeptides 1–3 in the crystalline state
The pentapeptides 1–3 produced suitable single crystals 1a–c,
2, and 3 for X-ray crystallographic analysis via the slow
evaporation of the relevant solvents at room temperature
[crystals 1a (MeOH/toluene), 1b (MeOH/EtOAc) and 1c
(chloroform/THF) of peptide 1; crystal 2 (MeOH/THF) of
peptide 2, and crystal 3 (MeOH/toluene) of peptide 3]. The
crystal structure and diffraction parameters of 1a–c, 2, and 3,
and known crystals A–B reported by Balaram are summarized
in Table 1. The relevant backbone and side torsion angles
and the intra- and intermolecular hydrogen bond parameters
of 1a–c, 2, and 3 are listed in Tables 2 and 3.
1
3322, 1736, 1673, 1651, 1537; H NMR (400 MHz, DMSO-d6):
δ 1.24 (s, 6H), 1.31 (s, 12H), 1.35 (s, 6H), 1.35 (s, 6H), 3.53 (s,
3H), 7.31 (br s, 1H), 7.39 (br s, 1H), 7.50 (br s, 1H), 7.79 (d, J
= 8.9 Hz, 2H), 7.84 (d, J = 8.7 Hz, 2H), 8.02 (br s, 1H), 8.19 (br
s, 1H); 13C-NMR (100 MHz, CD3OD): δ 23.7, 23.9, 24.1, 24.3,
24.6, 51.2, 55.7, 56.4, 56.5, 56.6, 59.0, 127.0, 128.1, 132.2,
142.3, 175.0, 175.2, 175.5, 175.8; MS (FAB): m/z 676 [M + H]+,
678 [M + H + 2]+; HRMS-FAB: m/z [M + Na]+ calcd for C27H42-
N5O8S79BrNa 698.1835, found 698.1836.
Crystal structure of 1a. Crystal 1a of pentapeptide 1
bearing the p-tolyl group was obtained in MeOH/toluene
¯
solution. The crystal belongs to the triclinic space group P1
and contains enantiomeric left-handed (M) and right-handed
(P) helical conformations in the unit cell (Fig. 1a). Disordered
toluene molecules filled the channel space (pore diameter: 4.9
Å), which consisted of helical enantiomers along the direction
perpendicular to the helical axis (Fig. 1b). The edge aromatic
hydrogen atoms on the electron-deficient tosyl ring interacted
with toluene molecules via intermolecular edge-to-face CH/π
aromatic interactions8 [the H to ring-centroid distance is 3.15
Å; the perpendicular distance from the H to the π-plane is
3.00 Å; the point of intersection of this perpendicular to the
plane is offset by 0.97 Å from the ring centroid; the
interacting aromatic rings adopt an orthogonal (85°) edge-
tilted-T arrangement] (Fig. 1c). The mean ϕ and ψ torsion
angles for the Aib residues (1–4) are +52.6° and +29.3° for the
left-handed helical conformation (Fig. 1d), which are close to
those for the ideal 310-helix conformations (+57° and +30°,
respectively).9 Reversal of the torsion angle signs was
observed at the C-terminal Aib(5) residues (ϕ5 = −47.8°, ψ5 =
−47.4°), which is frequently observed in 310-helical Aib. The
deviations of the ω angles for the Aib residues (1–5) from the
ideal value for the trans planar peptide bonds (180°) are small
(the average value is 4.6°). Three intramolecular i ← i + 3 type
hydrogen bonds with three consecutive type III′ β-turns were
found in the 310-helical molecules. They were located between
N(3)–H of Aib(3) and the SO oxygen atom in the SO2 group
[N(3)⋯O(SO2) = 3.01 Å], between N(4)–H of Aib(4) and O(1) of
ArSO2-(Aib)5-OMe (Ar = p-methoxyphenyl) 3
Following the typical procedure for the preparation of
sulfonamides, the reaction of H-(Aib)5-OMe 13 (46.1 mg, 0.10
mmol) with p-methoxybenzenesulfonyl chloride (26.9 mg,
0.130 mmol) afforded crude product 3 (36.4 mg, 0.058 mmol,
58%), which was recrystallized in n-hexane (2 mL)/CHCl3 (1
mL) to give the desired product 3 (27.2 mg, 0.0434 mmol,
43%) as a white solid. mp 227–235 °C; IR (KBr) (cm−1): 3350,
1
1728, 1668, 1652, 1520; H NMR (400 MHz, DMSO-d6): δ 1.22
(s, 6H), 1.31 (s, 12H), 1.35 (s, 6H), 1.36 (s, 6H), 3.53 (s, 3H),
3.84 (s, 3H), 7.13 (d, J = 8.9 Hz, 2H), 7.34 (br s, 1H), 7.38 (br
s, 1H), 7.56 (br s, 1H), 7.79 (d, J = 8.7 Hz, 2H), 7.93 (br s, 1H),
8.03 (br s, 1H); 13C-NMR (100 MHz, DMSO-d6): δ 24.8, 25.2,
25.3, 25.5, 25.8, 52.1, 55.3, 56.2, 56.5, 56.7, 59.1, 114.9, 128.9,
135.2, 162.7, 173.6, 174.4, 175.0, 175.1, 175.3; MS (FAB): m/z
628 [M + H]+; HRMS-FAB: m/z [M + Na]+ calcd for C28H45N5O9-
SNa 650.2836, found 650.2836.
X-ray crystallography
Single crystals were mounted on
a loop for the X-ray
measurements. Diffraction data were collected on an X-ray
diffractometer (Rigaku XtaLAB P200) equipped with a rotating
anode X-ray source (with multi-layer mirror monochromated
Mo-Kα, α = 0.71075 Å, and Cu-Kα, α = 1.54187 Å) and a hybrid
photon counting detector (PILATUS 200 K) at 93 K. The frame
This journal is © The Royal Society of Chemistry 2020
CrystEngComm, 2020, 22, 8353–8361 | 8355